Microvast Holdings announces departure of chief financial officer
LanzaTech Global, Inc., an industrial organic chemicals company with a market capitalization of $89 million, has received a notice from Nasdaq’s Listing Qualifications Department indicating that the company’s stock price has not met the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice comes as the stock has declined over 83% in the past year, according to InvestingPro data. The notice, which was issued on Monday, does not immediately affect LanzaTech’s listing, allowing its common stock to continue trading under the ticker "LNZA."
The Nasdaq Listing Rule 5550(a)(2), also known as the Bid Price Rule, requires that the closing bid price of a company’s stock be at least $1.00 per share. LanzaTech’s stock, currently trading at $0.41, has been closing below this threshold for the past 30 consecutive business days. To regain compliance, the company’s stock needs to close at or above $1.00 per share for at least ten consecutive business days within a 180-day period ending on September 9, 2025. InvestingPro analysis indicates the stock is currently in oversold territory, with 16 additional key insights available to subscribers.
If LanzaTech does not achieve compliance by the first deadline, it may be granted a second 180-day period to meet the requirements, provided it meets all other initial listing standards for The Nasdaq Capital Market, except for the Bid Price Rule. The company must also submit a written notice of its intention to correct the bid price deficiency.
Failure to meet the compliance requirements within the given timeframes could lead to delisting from Nasdaq. LanzaTech has stated it will monitor its stock’s closing bid price and explore available options to address the deficiency within the compliance periods. The company’s financial health score from InvestingPro is currently rated as ’Weak,’ though its current ratio of 2.91 indicates sufficient liquid assets to meet short-term obligations. However, there is no guarantee that LanzaTech will be able to regain compliance with the Bid Price Rule or maintain other listing requirements.
This development is based on a press release statement and reflects the current situation faced by LanzaTech as of today. The company, previously known as AMCI Acquisition Corp. II, is incorporated in Delaware and has its principal executive offices in Skokie, Illinois.
In other recent news, LanzaTech Global, Inc. has restructured its financial agreement with Brookfield Asset Management Inc (NYSE:BAM)., replacing a previous equity arrangement with a direct loan. This new loan agreement, dated February 14, 2025, provides LanzaTech with a total of $60,030,750, which includes the initial $50 million from the previous Simple Agreement for Future Equity (SAFE) and accumulated interest at an 8% annual rate. LanzaTech is required to make an initial repayment of $12.5 million by February 21, 2025, with the remaining balance due by October 3, 2027, unless certain conditions such as a change of control occur. The loan imposes restrictions on LanzaTech, including limitations on dividend payments and asset sales without Brookfield’s consent. Additionally, Brookfield gains the right to appoint an observer to LanzaTech’s Board of Directors. The Framework Agreement between LanzaTech and Brookfield remains unaffected by these changes. This financial restructuring highlights the ongoing partnership between the two companies, focusing on developing commercial facilities utilizing LanzaTech’s carbon capture technology. These developments underscore LanzaTech’s commitment to growth and technological advancements in sustainable chemical production.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.